Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lumped parameter modeling of changes in liver hemodynamics due to cirrhosis.

Biomechanics and modeling in mechanobiology·2026
Same author

Clinical-grade cryopreservation unlocks transplant-ready human pancreatic and stem cell-derived islets for diabetes therapy.

bioRxiv : the preprint server for biology·2026
Same author

Protecting laboratory air quality and comparing clinical assisted reproductive technology cycle outcomes before, during and after wildfire events: a retrospective cohort study.

Frontiers in reproductive health·2026
Same author

The use of therapeutic exosomes for <i>in vivo</i> wound healing.

Cell transplantation·2026
Same author

Cross-Cultural Evaluation of the Alcohol Relapse Risk Scale in an Australian Inpatient Setting.

Drug and alcohol review·2026
Same author

Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant tolerance.

Science advances·2026

Related Experiment Video

Updated: Jul 1, 2026

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
09:22

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

14.7K

Ischemia Reperfusion Injury Induced Systemic Inflammatory Response Following Interspecies Liver Transplantation.

Joseph Sushil Rao1,2, Parthasarathy Rangarajan2, Anala Shetty3

  • 1Division of Solid Organ Transplantation, Department of Surgery, University of Minnesota, Minneapolis, MN, USA.

Hepatic Medicine : Evidence and Research
|December 8, 2025
PubMed
Summary

Xenotransplantation immune responses, including inflammation and T cell proliferation, were comparable to allotransplants. Mitigating ischemia-reperfusion injury is crucial for successful exogenic organ transplantation without immunosuppression.

Keywords:
blastocyst complementationinterspecies transplantischemia reperfusion injurysystemic inflammatory response

More Related Videos

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

12.4K
Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model
10:07

Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model

Published on: March 6, 2021

5.5K

Related Experiment Videos

Last Updated: Jul 1, 2026

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
09:22

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model

Published on: April 2, 2017

14.7K
Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

12.4K
Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model
10:07

Organ Ischemia-Reperfusion Injury by Simulating Hemodynamic Changes in Rat Liver Transplant Model

Published on: March 6, 2021

5.5K

Area of Science:

  • Transplantation immunology
  • Inflammatory response
  • Xenotransplantation

Background:

  • Xenotransplantation research focuses on genetic modifications for graft survival and compatibility.
  • Exogenic organ generation via blastocyst complementation offers a promising alternative to immunosuppression.
  • Ischemia-reperfusion injury (IRI) activates inflammatory pathways, compromising graft survival.

Purpose of the Study:

  • To compare xeno-adaptive and acute inflammatory responses in mouse-to-rat liver xenografts versus rat allotransplants.
  • To establish baseline parameters for future anti-inflammatory strategies against IRI in exogenic liver transplantation.

Main Methods:

  • Heterotopic liver transplantation: mouse (C57BL/6) to rat (Lewis) xenografts.
  • Control group: rat (Sprague Dawley) to rat (Lewis) allotransplants.
  • Analysis included plasma cytokine/chemokine levels and mixed leukocyte reactions (MLR) for T cell proliferation.

Main Results:

  • Xenografts showed elevated plasma IL-2, IL-10, IL-13, IL-17A, TNF-a, and RANTES compared to controls.
  • Inflammatory marker levels in xenografts were not statistically different from allotransplants.
  • MLR revealed significant CD8+ T cell proliferation in xenografts, but not CD4+ T cell proliferation.

Conclusions:

  • Xenograft-induced inflammatory and adaptive responses were comparable to allotransplants.
  • Mitigating IRI-induced systemic inflammation is essential for exogenic organ transplantation success.
  • Future strategies should prioritize reducing inflammation to enhance graft tolerance and survival without immunosuppression.